Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Castlight Health (CSLT) Q2 Earnings: What's In The Cards?

Published 08/03/2016, 09:56 PM
Updated 07/09/2023, 06:31 AM

Castlight Health, Inc. (NYSE:CSLT) is set to report second-quarter 2016 results on Aug 8. Last quarter, the company posted a positive earnings surprise of 9.52%. Let us see how things are shaping up for this announcement.

Factors to Consider

Castlight Health operates as a provider of cloud-based software. It enables enterprises to gain control over their rapidly escalating health care costs.

The company reported encouraging first-quarter results. Revenues increased on a year-over-year basis and the reported loss also narrowed from the year-ago figure. Subscription revenues during the quarter came in at $21 million, up 41% on a year-over-year basis.

Castlight Health’s non-GAAP gross margin for the first quarter was 62.9%, up from 58.1% reported in the year-ago quarter. The year-over-year growth in gross margin was primarily due to a higher revenue base.

Furthermore, significant investments in growth areas for improving implementation timelines, particularly in case of upsell products, will boost profitability in the to-be reported quarter.

CASTLIGHT HLTH Price and EPS Surprise

CASTLIGHT HLTH Price and EPS Surprise | CASTLIGHT HLTH Quote

Earnings Whispers

Our proven model does not conclusively show that Castlight Health is likely to beat the Zacks Consensus Estimate in the upcoming release. This is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. Unfortunately, this is not the case here as elaborated below.

Zacks ESP: The Earnings ESP for Castlight Health is 0.00%. This is because both the Most Accurate estimate and the Zacks Consensus Estimate stand at a loss of 19 cents per share.

Zacks Rank: Castlight Health has a Zacks Rank #3. Though Zacks Rank #1, 2 or 3 increases the predictive power of ESP, the company’s ESP of 0.00% makes surprise prediction difficult.

We caution against stocks with a Zacks Rank #4 and 5 (Sell-rated stocks) going into the earnings announcement, especially when the company is seeing negative estimate revisions momentum.

Stocks to Consider

Here are some companies, which are worth considering, as our model shows that they have the right combination of these two elements:

Alamos Gold, Inc. (TO:AGI) , with an Earnings ESP of +100.0% and a Zacks Rank #2

Sun Life Financial Inc. (TO:SLF) , with an Earnings ESP of +1.47% and a Zacks Rank #2

Vivint Solar, Inc. (NYSE:VSLR) , with an Earnings ESP of +1.79% and a Zacks Rank #3

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


SUN LIFE FINL (SLF): Free Stock Analysis Report

VIVINT SOLAR (VSLR): Free Stock Analysis Report

ALAMOS GOLD INC (AGI): Free Stock Analysis Report

CASTLIGHT HLTH (CSLT): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.